Nasdaq · Biotech stocks database
OABI (OmniAb Inc.) stock: $5.03, $733.7M market cap, $64.2M cash, $669.5M EV, $995.4M fully diluted market cap. Data from Fully Diluted's biotech stocks database.
Our technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for our partners’ drug development efforts. At the heart of the OmniAb platform is what we call Biological Intelligence TM , which powers the immune systems of our proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
Source: 10-K FY2025 via SEC EDGAR
| Cash | $64.2M |
|---|---|
| Debt | $0.0M |
| Net cash | $64.2M |
| Enterprise value | $669.5M |
| Basic shares | 145.9M shares |
| Fully diluted shares | 197.9M shares |
| Fully diluted market cap | $995.4M |
| Cash per share | $0.44 |
| Quarterly burn | +$2.7M generated |
Cash figures as of 2026-09-30. Database snapshot: 2026-11-07.
Cap table as of 2026-06-30.
Loading OABI daily closes…